Last reviewed · How we verify
NCT01534923
Doctor-Patient Communication About Colorectal Cancer Screening
trial testing surveys in Colorectal Cancer Screening in 76 participants. Completed in 26 December 2019.
26 December 2019
Quick facts
| Lead sponsor | Memorial Sloan Kettering Cancer Center |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 76 |
| Start date | 7 February 2012 |
| Primary completion | 26 December 2019 |
| Estimated completion | 26 December 2019 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- surveys
Conditions studied
- Colorectal Cancer Screening — all drugs for Colorectal Cancer Screening →
Sponsor
Memorial Sloan Kettering Cancer Center — full company profile →
Who can join
Adults 50 to 75, any sex, with Colorectal Cancer Screening. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to learn more about doctor-patient communication about colon cancer screening. This study will also look to see if there are differences in those who get colon cancer screening based on the discussion the doctor had with the patient.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT01534923
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of surveys
Trials testing the same drug.
- NCT07536672 — VALIDITY AND RELIABILITY OF THE TURKISH VERSION OF THE SEX PAIN QUESTIONNAIRE · enrolling by invitation
- NCT06475963 — Evaluation of Clinical Outcomes of Scaffold Treatment of Partial Meniscal Injuries of the Knee · completed
- NCT04304469 — Management of Women Who Experience Domestic Abuse: Study Comparing Psychological Outcomes at the Maison Des Femmes in Sa · completed
- NCT04164342 — Prevalence of Chronic Pain and Its Risk Factors After a Surgical Intensive Care Unit Stay. Prospective Observational Coh · NA · completed
- NCT03395275 — Intrathecal Morphine Microdose Method Sensory Changes · NA · withdrawn
Other recruiting trials for Colorectal Cancer Screening
Currently open trials in the same condition.
- NCT06757192 — CRC Screening in Unscreened Individuals 45-54 · recruiting
- NCT06763432 — Positive Fit to Colonoscopy: Closing the Gap · recruiting
- NCT06821009 — Effectiveness of a Cloud-based Digital Health Navigation Program for Colorectal Cancer Screening · NA · recruiting
- NCT06666556 — Bowel Preparation in Colonoscopy: Lactulose Vs Polyethyleneglycol, Randomized Double-blind Comparative Clinical Trial, M · Phase 4 · recruiting
- NCT07224750 — A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer · recruiting
Other Memorial Sloan Kettering Cancer Center trials
Trials by the same sponsor.
- NCT07566377 — Cord Blood Transplantation in Children and Young Adults With Blood Cancer · Phase 2 · recruiting
- NCT07507643 — A Study of Methylprednisolone in People Having Liver Surgery · Phase 3 · recruiting
- NCT07483307 — A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Breast Cancer · Phase 2 · recruiting
- NCT07459673 — HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term · Phase 2 · recruiting
- NCT07449195 — A Study Comparing Two Optical Coherence Tomography Devices in People With Ocular Tumors · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01534923 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center
- Last refreshed: 2 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01534923.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing